Steris | STE - Loan Capital



Steris reported $1.9B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
3M USD 12.48B 170M Jun/2025
Avanos Medical USD 95.7M 2.3M Jun/2025
Baxter International USD 9.41B 962M Mar/2025
Becton, Dickinson and Co. USD 17.53B 135M Jun/2025
Boston Scientific USD 10.53B 1.56B Mar/2025
CONMED USD 881.11M 10.33M Jun/2025
Cooper Companies USD 2.43B 96.1M Jul/2025
Dexcom USD 1.24B 56.7M Jun/2025
Ecolab USD 7.52B 524.6M Jun/2025
Edwards Lifesciences USD 597.8M 100K Mar/2025
Fortive USD 2.91B 22.6M Jun/2025
Getinge SEK 8.28B 1.08B Dec/2024
Globus Medical USD 173K 84K Jun/2025
Haemonetics USD 920.83M 397K Jun/2025
Hologic USD 2.51B 37.5M Jun/2025
Idexx Laboratories USD 449.81M 13K Jun/2025
Insulet USD 939M 673.3M Jun/2025
Integra LifeSciences USD 1.23B 3.7M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 38.36B 7.7B Mar/2025
Masimo USD 598.7M 37.3M Jun/2025
Olympus JPY 231.74B 97.62B Jun/2025
Owens Minor USD 1.9B 89.47M Mar/2025
ResMed USD 658.39M 4.73M Jun/2025
Steris USD 1.9B 15.6M Jun/2025
Stryker USD 14.83B 446M Jun/2025
Tandem Diabetes Care USD 309.15M 4.46M Jun/2025
Teleflex USD 1.8B 5.68M Jun/2025
Thermo Fisher Scientific USD 33.02B 1.64B Jun/2025
Zimmer Biomet Holdings USD 6.75B 176.2M Jun/2025